Stock AYA ARTRYA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Artrya Limited

Equities

AYA

AU0000182412

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 08:58:04 2024-05-16 pm EDT 		5-day change 1st Jan Change
0.285 AUD +1.79% Intraday chart for Artrya Limited -8.06% +18.75%
Apr. 02 Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8% MT
Mar. 12 Artrya Gears Up for US Launch After Tanner Health System Partnership MT

Valuation

Fiscal Period: June 2022 2023
Capitalization 1 50.86 17.28
Enterprise Value (EV) 1 16.67 -1.915
P/E ratio -2.51 x -1.55 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA -1.01 x 0.17 x
EV / FCF -1,501,356 x 145,615 x
FCF Yield -0% 0%
Price to Book 1.25 x 0.57 x
Nbr of stocks (in thousands) 78,248 78,539
Reference price 2 0.6500 0.2200
Announcement Date 8/31/22 8/31/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2020 2021 2022 2023
Net sales - - - -
EBITDA 1 -1.344 -4.02 -16.44 -11.05
EBIT 1 -1.347 -4.03 -16.59 -11.45
Operating Margin - - - -
Earnings before Tax (EBT) 1 -1.354 -4.08 -16.62 -11.12
Net income 1 -1.354 -4.08 -17.16 -11.14
Net margin - - - -
EPS 2 -0.0606 -0.1185 -0.2592 -0.1421
Free Cash Flow - -3.246 -11.1 -13.15
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 11/24/21 11/24/21 8/31/22 8/31/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 2.22 12.9 34.2 19.2
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - -3.25 -11.1 -13.2
ROE (net income / shareholders' equity) - -49.8% -62.9% -31.3%
ROA (Net income/ Total Assets) - -28.4% -35.2% -18.6%
Assets 1 - 14.36 48.77 59.9
Book Value Per Share 2 0.1100 0.2900 0.5200 0.3900
Cash Flow per Share 2 0.1000 0.2700 0.2000 0.2600
Capex 1 0.02 0.09 1.88 0.29
Capex / Sales - - - -
Announcement Date 11/24/21 11/24/21 8/31/22 8/31/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
ARTRYA LIMITED Stock Artrya Limited
+18.75% 14.71M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.99% 8.67B
RADNET, INC. Stock RadNet, Inc.
+65.21% 4.25B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-1.10% 2.51B
SYNLAB AG Stock SYNLAB AG
-10.68% 2.47B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-41.76% 2.25B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-9.36% 1.91B
FLEURY S.A. Stock Fleury S.A.
-19.79% 1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-39.61% 1.19B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+9.54% 1.15B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. AYA Stock
  4. Financials Artrya Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW